Anbesol
- Product NDC
- 80070-220
- 11-digit product format
- 800700220
- Labeler code
- 80070
- Product ID
- 80070-220_2e81b590-9c95-4fcf-e063-6394a90ab555
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- BENZOCAINE
- Dosage form
- GEL
- Route
- TOPICAL
- Labeler
- Foundation Consumer Brands
- Application
- M022
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-09-15
- Substance
- BENZOCAINE
- Active strength
- 200 mg/g
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Anbesol
- Brand name suffix
- Maximum Strength
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BENZOCAINE | 200 mg/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | U3RSY48JW5 |
| Rxcui | 238910, 1052633 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 80070-220-33 | AnbesolMaximum Strength | 9 g in 1 TUBE | GEL | 9 | | 4 |
| 80070-220-33 | AnbesolMaximum Strength | 1 in 1 BLISTER PACK | GEL | 1 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 80070-220 | ANBESOL MAXIMUM STRENGTH (BENZOCAINE) GEL [FOUNDATION CONSUMER BRANDS] | 4 | Current NDC, Legacy NDC, 2 package rows | 20250221_dcc37403-0192-4658-bb7a-059273ce0047.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 80070-220-33 | 80070022033 | 1 TUBE in 1 BLISTER PACK (80070-220-33) / 9 g in 1 TUBE | 1 tube | 2021-09-15 | 0000-00-00 | No | No | Current |